Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.46 |
| ▸ | CHKA | P35790 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | LOX | P28300 | 1/20 | 0.42 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31098970 | 0.78 | CHKA (0.49) | ALDH1A1KDM4ECHKARECQLLOX | |
| SCHEMBL1400929 | 0.77 | ALDH1A1 (0.46) | ALDH1A1KDM4ERECQLLOXLOXL3 | |
| SCHEMBL4183371 | 0.77 | ALDH1A1 (0.42) | ALDH1A1KDM4ENPC1RECQLLOX | |
| SCHEMBL196641 | 0.76 | ALDH1A1 (0.53) | ALDH1A1KDM4ECHRM5CHKANPC1 | |
| SCHEMBL1857798 | 0.74 | UHRF1 (0.52) | ALDH1A1KDM4ECHRM5CHKATERT | |
| SCHEMBL18221640 | 0.74 | ALDH1A1 (0.52) | ALDH1A1KDM4ECHRM5CHKANPC1 | |
| SCHEMBL30002302 | 0.74 | UHRF1 (0.52) | ALDH1A1KDM4ECHRM5CHKATERT | |
| SCHEMBL2641921 | 0.74 | MAPT (0.61) | ALDH1A1NPC1APPALOX15MAPT | |
| SCHEMBL2641925 | 0.74 | MAPT (0.61) | ALDH1A1NPC1APPALOX15MAPT | |
| SCHEMBL18598911 | 0.74 | MAPT (0.41) | ALDH1A1KDM4ERECQLLOXLOXL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240219366-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SCHWEIZ AG (CH) | 2024-07-04 | — | — | US | claimed |
| EP-4327073-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SE (DE) | 2024-02-28 | — | — | EP | claimed |
| WO-2022223384-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SE (DE) | 2022-10-27 | — | — | WO | claimed |
| EP-3202862-A2 | CHROMOPHORIC COMPOSITIONS | BASF SE (DE) | 2017-08-09 | — | — | EP | claimed |
| EP-3067216-A1 | CHROMOPHORIC COMPOSITIONS | BASF SE (DE) | 2016-09-14 | — | — | EP | claimed |
| US-20240219366-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SCHWEIZ AG (CH) | 2024-07-04 | — | — | US | disclosed |
| EP-4327073-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SE (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2022223384-A1 | A METHOD OF DETECTING ONE OR MORE MARKERS IN A PETROLEUM FUEL USING A PHOTOACOUSTIC DETECTOR | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
| WO-2017175068-A1 | THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS | MANKIND PHARMA LTD. (IN) | 2017-10-12 | — | — | WO | disclosed |
| EP-3202862-A2 | CHROMOPHORIC COMPOSITIONS | BASF SE (DE) | 2017-08-09 | — | — | EP | disclosed |
| EP-3067216-A1 | CHROMOPHORIC COMPOSITIONS | BASF SE (DE) | 2016-09-14 | — | — | EP | disclosed |
| US-8680275-B2 | Fused heterocyclic compounds as orexin receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2014-03-25 | — | — | US | disclosed |
| EP-2491034-B1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2013-12-18 | — | — | EP | disclosed |
| EP-2491034-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2012-08-29 | — | — | EP | disclosed |
| US-20120202783-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN RESEARCH NV (BE) | 2012-08-09 | — | — | US | disclosed |
| WO-2011050200-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-04-28 | — | — | WO | disclosed |
| WO-2009029617-A1 | DIARYLAMINE-SUBSTITUTED QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009029617-A1 | DIARYLAMINE-SUBSTITUTED QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202783-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | HCRTR2, HCRTR1, OXTR | ALDH1A1 2475/4885KDM4E 1368/4885CHRM5 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.